Allorestricted peptide-specific T cells
View Patent ↗The present invention is directed to a T cell receptor (TCR) recognizing antigenic peptides derived from tumor-associated antigen FMNL1/KW13 and being capable of inducing peptide specific killing of a target cell. The present invention is further directed to one antigenic peptides derived from tumor-associated antigen FMNL1/KW13, to an antigen specific T cell, comprising said TCR, to a nucleic acid coding for said TCR and to the use of the antigen specific T cells for the manufacture of a medicament for the treatment of malignancies characterized by overexpression of FMNL1/KW13.
1. An isolated T cell receptor (TCR) that specifically recognizes an antigenic peptide bound to human leukocyte antigen A2 (HLA-A2), wherein the antigenic peptide has the amino acid sequence of SEQ ID NO: 2.